- Location
autoimmune diseases
"-
Rayvio and Boston University Expand UV LED Research to Combat Vitamin D Deficiency Disorders
Aug 1, 2016Health and hygiene company RayVio Corp of Haywood, CA, USA, which is commercializing deep-ultraviolet (UV) LEDs and consumer disinfection solutions, is expanding a research program with Boston University to develop new treatments for ...
-
Bosch Demonstrated Its Rotary Pen Assembly Machine Mra for The Medical Devices Industry
Jun 29, 2015Bosch Packaging Technology has demonstrated its rotary pen assembly machine MRA for the medical devices industry, at Achema in Frankfurt, Germany. The device, designed by Bosch subsidiary Moeller & Devicon, assembles pens or injectors ...
Tags: Bosch Packaging Technology, MAR, newly-designed device, packaging machine
-
Medac Pharma Has Reported FDA Acceptance of a NDA for Its Lead Product Candidate
Feb 7, 2014US-based Medac Pharma has reported the US Food and Drug Administration (FDA) acceptance of a new drug application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection ...
-
A Molecule Linked to Clogged Arteries Might Activate The Immune System to The Point
Jan 10, 2014New research in mice suggests that a molecule linked to clogged arteries might activate the immune system to the point where it harms the body. The findings may explain why clogged arteries, a condition called atherosclerosis, have been ...
-
Low Levels of The "Sunshine Vitamin" Are More Likely a Consequence of Illness
Dec 27, 2013Low levels of vitamin D have been implicated as a potential cause of diseases ranging from cancer to diabetes. Now an extensive review suggests it's really the other way around: Low levels of the "sunshine vitamin" are more likely a ...
Tags: vitamin D, cancer, diabetes, low levels of vitamin D
-
EFAs Are Essential Fatty Acids
Nov 19, 2013EFAs are essential fatty acids, which we need to live but our bodies cannot create. So we need take EFAs from outside sources. Johanna Budwig, the creator of the Budwig Diet for successfully treating cancer, claimed before she died at age ...
Tags: EFA, inflammation, adrenal
-
KARO Has Achieved Its First Milestone in a Research Agreement with Pfizer
Sep 9, 2013Swedish biotechnology firm Karo Bio (KARO) has achieved its first milestone in a research agreement with Pfizer for the development of drugs for treatment of autoimmune diseases. The achievement of milestone in the RORgamma project ...
-
Histogenetics Selected Illumina's Miseq Sequencing System for Use in Its Clia Laboratory
Jul 25, 2013HistoGenetics, a New York-based biotech firm specialized in Human Leukocyte Antigen (HLA) typing services and Sequenced-Based Typing (SBT), has selected Illumina's MiSeq sequencing system for use in its CLIA laboratory. Illumina's MiSeq ...
-
The Commercial Pet Foods Industry Rakes in Billions of Dollars Annually
Apr 19, 2013The commercial pet foods industry rakes in billions of dollars annually.In exchange for our dollars,we trust the companies to provide our pets with quality nutrition.The recent pet food recall demonstrated that our trust has been ...
-
arGEN-X Has Progressed Fourth Therapeutic Candidate Into Formal Preclinical Development
Mar 27, 2013Belgium-based clinical stagebiopharmaceutical company arGEN-X has progressed its fourth therapeutic candidate, ARGX-112, into formal preclinical development. The new human antibody ARGX-112 neutralizes both IL20 and IL22 signaling through ...
Tags: preclinical development, clinical stagebiopharmaceutical, Medicine
-
MRC Technology Announced a Pound 577,000 Funding Award From The Biomedical Catalyst
Jan 16, 2013MRC Technology, a technology transfer charity and company, announced at the end of last year a pound 577,000 funding award from the Biomedical Catalyst. The award has been granted to MRC Technology to fund research into the role of ...
-
Daiichi Sankyo and Amplimmune Have Collaborated to Develop AMP-110 Therapeutic Protein
Jan 9, 2013Daiichi Sankyo and Amplimmune have collaborated to develop AMP-110 therapeutic protein for the treatment of autoimmune diseases. The companies expect to commence Phase 1 study of the AMP-110 immune modulation therapy, which targets ...
Tags: Daiichi Sankyo, Amplimmune, therapeutic protein, autoimmune diseases
-
Genalyte Has Unveiled Maverick Ena 4 and Ena 6 Assay Kits.
Dec 18, 2012Genalyte, a provider of multiplex detection technologies, has unveiled Maverick ENA 4 and ENA 6 assay kits. The Maverick ENA 4 and ENA 6 assay kits, which are designed for use on the company's Maverick Detection system, simultaneously ...
-
Stiefel Has Acquired The Development and Commercialization Rights
Nov 30, 2012Stiefel, a GSK company, has acquired the development and commercialization rights to Welichem Biotech (WBI) anti-inflammatory agent, WBI-1001. The acquisition follows the previously announced asset purchase agreement. WBI-1001 ...
Tags: acquisition, clinical drugs, Stiefel
-
Abgenomics Got Approved From FDA on The Novel Autoimmune Therapeutic Candidate
Aug 20, 2012AbGenomics International, a biopharmaceutical company, has obtained FDA agreement on Its Phase 2 clinical trial plans of the novel autoimmune therapeutic candidate, AbGn-168H. The current Phase 2 AbGn-168H trial will be a multicenter, ...
Tags: FDA approval, psoriatic, clinical trial, pharmaceutical product
Related Products
-
Prednisone Acetate Tablets for Rednisone Acetate Tablets
-
Hot! Wholesale High Purity 99% Vitamin D3 Feed Grade
-
Vitamin D3 500 Vd3 500 Feed Aditive Factory Price
-
Aminal Feed Vitamin D3 Powder/Granular
-
Prednisone Acetate Tablets for Autoimmune Inflammatory Disease
-
Prednisone Acetate Tablets for Malignant Lymphoma
